(Q34091402)

31 July 2017

title

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy (English)

1 reference

31 July 2017

1

Michael L Eisenberg

1 reference

31 July 2017

Matthew R Cooperberg

3

0 references

author name string

Benjamin J Davies

series ordinal

2

1 reference

31 July 2017

Janet E Cowan

series ordinal

4

1 reference

31 July 2017

Peter R Carroll

series ordinal

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

3 April 2009

1 reference

31 July 2017

1 reference

31 July 2017

volume

57

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

622-629

1 reference

Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

High-risk prostate cancer in the United States, 1990-2007

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Prostate specific antigen recurrence after definitive therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Natural history of progression after PSA elevation following radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Biochemical markers in prostatic cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Who is the average patient presenting with prostate cancer?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Biological determinants of cancer progression in men with prostate cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930030

Gamma-carboxyglutamate in normal and pathological human middle ear bones

28 October 2018

1 reference

12 December 2020

Relative reliability of five serially measured markers for prognosis of progression in prostate cancer

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy

1 reference

12 December 2020

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

The Actual Value of the Surgical Margin Status as a Predictor of Disease Progression in Men with Early Prostate Cancer

1 reference

12 December 2020

The relationship of ultrasensitive measurements of prostate-specific antigen levels to prostate cancer recurrence after radical prostatectomy

1 reference

12 December 2020

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

1 reference

12 December 2020

Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study

1 reference

12 December 2020

10.1016/J.EURURO.2009.03.077

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference